CIK 0001885522 · Non-accelerated filer<br>Smaller reporting company
Neumora Therapeutics, Inc.
Sign in to watch- Ticker
- NMRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 844367680
- Phone
- (857) 760-0900
- Business address
- 260 ARSENAL PLACE, SUITE 1, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $701,641
- in 2 filings
Net −$701,641. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-09-14 | Burow Kristina Director | Grant or award · Stock Option (Right to Buy) | +46,455 | 46,455 | ||
| 2023-09-14 | Halawa Alaa Director | Grant or award · Stock Option (Right to Buy) | +46,455 | 46,455 | ||
| 2023-09-14 | Fust Matthew K Director | Grant or award · Stock Option (Right to Buy) | +27,802 | 27,802 | ||
| 2023-09-14 | Ho Maykin Director | Grant or award · Stock Option (Right to Buy) | +27,802 | 27,802 |
Page 20 of 20 · 384 trades